Neoadjuvant Chemoradiotherapy Affects the Indications for Lateral Pelvic Node Dissection in Mid/Low Rectal Cancer with Clinically Suspected Lateral Node Involvement: A Multicenter Retrospective Cohort Study

详细信息    查看全文

• 作者：Heung-Kwon Oh MD (1)
  Sung-Bum Kang MD ; PhD (1)
  Sung-Min Lee MD (1)
  Soo Young Lee MD (1)
  Myoung Hun Ihn MD (1)
  Duck-Woo Kim MD ; PhD (1)
  Ji Hoon Park MD (2)
  Young Hoon Kim MD ; PhD (2)
  Kyung Ho Lee MD ; PhD (2)
  Jae-Sung Kim MD ; PhD (3)
  Jin Won Kim MD (4)
  Jee Hyun Kim MD ; PhD (4)
  Tae-Young Chang MD (5)
  Sung-Chan Park MD ; PhD (5)
  Dae Kyung Sohn MD ; PhD (5)
  Jae Hwan Oh MD ; PhD (5)
  Ji Won Park MD (6)
  Seung-Bum Ryoo MD (6)
  Seung-Yong Jeong MD ; PhD (6)
  Kyu Joo Park MD ; PhD (6)
  
• 刊名：Annals of Surgical Oncology
• 出版年：2014
• 出版时间：July 2014
• 年：2014
• 卷：21
• 期：7
• 页码：2280-2287
• 全文大小：
• 参考文献：1. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. / J Natl Cancer Inst. 2001;93:583-6. CrossRef
  2. Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. / Lancet Oncol. 2009;10:1053-2. CrossRef
  3. Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. / Dis Colon Rectum. 2008;51:284-1. CrossRef
  4. Monson JR, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). / Dis Colon Rectum. 2013;56:535-0. CrossRef
  5. Benson A III, Bekaii-Saab T, Chan E. NCCN clinical practice guidelines in oncology: rectal cancer. Version 4. 2013. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.
  6. Shihab OC, Taylor F, Bees N, et al. Relevance of magnetic resonance imaging–detected pelvic sidewall lymph node involvement in rectal cancer. / Br J Surg. 2011;98:1798-04. CrossRef
  7. Nagawa H, Muto T, Sunouchi K, et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. / Dis Colon Rectum. 2001;44:1274-0. CrossRef
  8. Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. / Lancet Oncol. 2012;13:616-1. CrossRef
  9. Koch M, Kienle P, Antolovic D, Buchler MW, Weitz J. Is the lateral lymph node compartment relevant? / Recent Results Cancer Res. 2005;165:40-. CrossRef
  10. Wang Z, Loh KY, Tan KY, Woo EC. The role of lateral lymph node dissection in the management of lower rectal cancer. / Langenbecks / Arch Surg. 2012;397:353-1. CrossRef
  11. Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. / Ann Surg Oncol. 2008;15:729-7. CrossRef
  12. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. / N Engl J Med. 1997;336:980-.
  13. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. / N Engl J Med. 2001;345:638-6. CrossRef
  14. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. / Lancet Oncol. 2011;12:575-2. CrossRef
  15. Watanabe T, Tsurita G, Muto T, et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. / Surgery. 2002;132:27-3. CrossRef
  16. Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. / Ann Surg. 2009;249:229-5. CrossRef
  17. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. / Lancet Oncol. 2010;11:637-5. CrossRef
  18. Kim YH, Kim DY, Kim TH, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. / Int J Radiat Oncol Biol Phys. 2005;62:761-. CrossRef
  19. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. / Eur Radiol. 2011;21:987-5. CrossRef
  20. Kim MJ, Kim KG, Lee JH, et al. Analysis of the anatomical characteristics of the pelvis in Koreans to aid in development of a NOTES platform. / Surg Innov. 2013;20:134-1. CrossRef
  21. Ueno H, Mochizuki H, Hashiguchi Y, et al. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. / Ann Surg. 2007;245:80-. CrossRef
  22. Matsuoka H, Nakamura A, Masaki T, et al. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. / Anticancer Res. 2007;27(5B):3529-3.
  23. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. / World J Surg. 1997;21:728-2. CrossRef
  24. Kyo K, Sameshima S, Takahashi M, Furugori T, Sawada T. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. / World J Surg. 2006;30:1014-. CrossRef
  25. Edge SB, Byrd DR, Compton CC, Fritz AG. AJCC cancer staging manual. 7th ed. New York: Springer; 2009.
  26. Liang JT. Technical feasibility of laparoscopic lateral pelvic lymph node dissection for patients with low rectal cancer after concurrent chemoradiation therapy. / Ann Surg Oncol. 2011;18:153-. CrossRef
  27. Park JS, Choi GS, Lim KH, et al. Laparoscopic extended lateral pelvic node dissection following total mesorectal excision for advanced rectal cancer: initial clinical experience. / Surg Endosc. 2011;25:3322-. CrossRef
  28. Beaumont C, Pandey T, Gaines Fricke R, Laryea J, Jambhekar K. (2013) MR evaluation of rectal cancer: current concepts. / Curr Probl Diagn Radiol. 2013;42:99-12. CrossRef
  29. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. / Radiology. 2003;227:371-. CrossRef
  30. Min BS, Kim JS, Kim NK, et al. Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. / Ann Surg Oncol. 2009;16:3271-. CrossRef
  31. Beets-Tan RG, Lambregts DM, Maas M, et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. / Eur Radiol. 2013;23:2522-1. CrossRef
  32. Koda K, Saito N, Oda K, Takiguchi N, Sarashina H, Miyazaki M. Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. / Int J Colorectal Dis. 2004;19:188-4. CrossRef
  33. Mann B. Lateral lymph node dissection in rectal cancer patients: is there any indication? / Int J Colorectal Dis. 2004;19:195-. CrossRef
  34. Yano H, Moran BJ. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. / Br J Surg. 2008;95:33-9. CrossRef
  35. Quadros CA, Falcao MF, Carvalho ME, Ladeia PA, Lopes A. Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma. / J Surg Oncol. 2012;106:653-. CrossRef
  36. Takahashi T, Ueno M, Azekura K, Ohta H. Lateral node dissection and total mesorectal excision for rectal cancer. / Dis Colon Rectum. 2000;43(10 Suppl):S59-8. CrossRef
  37. Uyama I, Sugioka A, Matsui H, et al. Laparoscopic lateral node dissection with autonomic nerve preservation for advanced lower rectal cancer. / J Am Coll Surg. 2001;193:579-4. CrossRef
  
• 作者单位：Heung-Kwon Oh MD (1)
  Sung-Bum Kang MD, PhD (1)
  Sung-Min Lee MD (1)
  Soo Young Lee MD (1)
  Myoung Hun Ihn MD (1)
  Duck-Woo Kim MD, PhD (1)
  Ji Hoon Park MD (2)
  Young Hoon Kim MD, PhD (2)
  Kyung Ho Lee MD, PhD (2)
  Jae-Sung Kim MD, PhD (3)
  Jin Won Kim MD (4)
  Jee Hyun Kim MD, PhD (4)
  Tae-Young Chang MD (5)
  Sung-Chan Park MD, PhD (5)
  Dae Kyung Sohn MD, PhD (5)
  Jae Hwan Oh MD, PhD (5)
  Ji Won Park MD (6)
  Seung-Bum Ryoo MD (6)
  Seung-Yong Jeong MD, PhD (6)
  Kyu Joo Park MD, PhD (6)
  
  1. Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
  2. Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
  3. Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
  4. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
  5. Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
  6. Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
  
• ISSN：1534-4681

文摘

Background Although lateral pelvic node dissection (LPND) is recommended for rectal cancer with clinically metastatic lateral pelvic lymph nodes (LPNs), LPNs may respond to neoadjuvant chemoradiotherapy (nCRT). Our aim was to determine the optimal indication for LPND after nCRT for mid/low rectal cancer. Methods Of 2,263 patients with clinical stage II/III mid/low rectal cancer who were managed at three tertiary referral hospitals, 66 patients underwent curative surgery including LPND after nCRT were included in this study. Risk factors for LPN metastasis were retrospectively analyzed and oncologic outcomes determined according to LPN response to nCRT. Results Persistent LPNs greater than 5?mm on post-nCRT magnetic resonance imaging were significantly associated with residual tumor metastasis, unlike responsive LPN after nCRT (short-axis diameter ??mm) (pathologically, 61.1?% [22 of 36] vs. 0?% [0 of 30], P?<?0.001). Multivariable analysis revealed post-nCRT LPN size as a significant and independent risk factor for LPN metastasis (odds ratio 2.390; 95?% confidence interval 1.104-.069). Over a median follow-up of 39.3?months, the recurrence rate was lower in patients with responsive nodes than in patients with persistent nodes (20?% [6 of 30] vs. 47.2?% [17 of 36], P?=?0.012). The 5-year overall survival and 5-year disease-free survival rates were lower in patients with persistent LPN than in patients with responsive LPN (44.6?% vs. 77.1?%, P?=?0.034; 33.7?% vs. 72.5?%, P?=?0.011, respectively). Conclusions In mid/low rectal cancer with clinically metastatic LPNs, the decision to perform LPND should be based on the LPN response to nCRT.